Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute
API

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

TARGETSITE THERAPEUTICS CORPORATION — Funding, Investors & Profile — Capbase

← All companies

Compare History

TARGETSITE THERAPEUTICS CORPORATION

Private

Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: HUAKPCHL21Q6

Founded: —Source: [GOV]
Headquarters: New Haven, ConnecticutSource: [GOV]
Country: United StatesSource: [GOV]
Headcount: 3Source: [GOV]

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

TARGETSITE THERAPEUTICS CORPORATION has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $564,794 between 2021 and 2023. These are non-dilutive federal research grants, not equity financing. The company is based in New Haven, Connecticut.

Funding rounds

2 rounds

2 rounds · latest SBIR Phase I award (HHS), Aug 2023

Investors

No investors recorded yet for TARGETSITE THERAPEUTICS CORPORATION.

Add an investor

People

Leadership

VINOD S RAMGOLAMPrincipal investigatorSince 2023Source: [GOV]

Acquisitions

TARGETSITE THERAPEUTICS CORPORATION has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for TARGETSITE THERAPEUTICS CORPORATION.

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Stage

Seed

Sector

Healthcare